|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical Mergers and Acquisitions
Cutting Edge Information, Oct 2009, Pages: 175
Pharmaceutical Mergers and Acquisitions guides you to build an M&A plan that focuses on key goals, avoids costly mistakes, and realizes deal potential as quickly as possible. CEI designed this study to identify the primary drivers of M&A activity. Through the input of pharma industry leaders, our study provides solutions to the greatest M&A pitfalls and gives clear, detailed insight of trends in pharmaceutical deals. The result: a roadmap to the M&A landscape.
The past year has been marked by heightened M&A activity among companies of all sizes. Small companies are increasingly investing in large-molecule products that are expensive to produce and test in clinical trials - but in this tough economic climate, they face diminishing capital and the threat of closing. To continue their work on time-sensitive compounds, they are exploring the possibility of a company sale. On the other hand, for those companies with cash, this situation presents an opportunity to acquire attractive compounds and technology platforms at a discount.
Timelines, rankings, strategies, and deal profiles will allow you to maximize the benefits and growth opportunities of a deal:
Understand The M&A Environment:
- Learn what is driving the acquisition strategies of top companies and how other organizations are seeking suitors for their own sales.
Build A Competitive Deal-Making Process:
- Target the right deals with an M&A task force
- Implement a timeline that works for both sides
- Track different types of financing across deals brokered by companies of different sizes
Complete The Integration As Soon As Possible And Boost Productivity:
- Build an integration timeline
- Clarify roles and responsibilities in the new organization
- Reduce the impact of attrition
Learn From The Recent Past:
We've vetted the top 75 deals of 2009 to determine purchasing trends, including:
- Price/pipeline ratios
- Financing options
- Deal motivators
Look Into The Future Of M&A:
Gather perspectives and predictions on future deals from the managers who execute them.
Compare Your Deal To Others:
- Use the deal profiles to compare metrics for 19 different deals
- Explore deal size, functional involvement in deal-making, timelines, challenges and employee retention
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
Partnering Agreements in Pharma and Biotech Yearbook 2010
The Future of Contract Research Outsourcing - Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking
Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost - Effective Purification Technologies
Health Economics and Outcomes Research: US, Europe, Canada & Emerging Markets
Hospital Acquired Bacterial Infections Market to 2016 - Increasing Antibiotic Resistance and Increasing Population of Critically Ill Patients To Drive Growth
Pharmaceutical Business Development and Licensing: Strengthening Pipelines and Managing Relationships
Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost
|
|
|
|
